Injectable Potassium Phosphate Market
Market Insights on Injectable Potassium Phosphate covering sales outlook, demand forecast & up-to-date key trends
Injectable Potassium Phosphate Market : Global Industry Analysis 2016 - 2020 and Opportunity Assessment 2021 - 2031
Injectable Potassium Phosphate Market Overview
According to the latest research by Future Market Insights, the injectable potassium phosphate market is set to experience ~8.6% (CAGR) growth during the year 2021-2031.
The injectable potassium phosphate is a phosphorus replacement product indicated as a source of phosphorus.
The growth of the injectable potassium phosphate market is attributed due to the increasing number of patients who cannot receive a phosphate supplement by mouth and the rising prevalence of hyperphosphatemia, hypercalcemia, hyperkalaemia, or significant hypercalcemia and severe renal impairment or end-stage renal disease in patients.
What is Driving Demand for Injectable Potassium Phosphate Market
In patients with restricted oral intake, potassium phosphates injection is chosen as a source of phosphorus in addition to high volume venous fluids to prevent hypophosphatemia. In addition to the rising need for potassium phosphate in renal diseases, the global market is expanding rapidly.
The need for potassium phosphate has been boosted by an increase in the number of uric acid and calcium kidney stone illnesses, as well as urinary problems.
The U.S. and Canada Outlook for Injectable Potassium Phosphate Market
The U.S. is expected to have the highest share and therefore will dominate the injectable potassium phosphate market. In the U.S. the large population's dietary intake is poor and have a deficiency of potassium phosphate.
The U.S market is growing at a substantial pace due to the growing demand for potassium phosphate injectable in kidney ailments and prevents hypophosphatemia low phosphorus content in the blood.
There is an escalation in the number of uric acid & calcium kidney stone diseases and urination disorders in the patients has actively uplifted the demand for potassium phosphate.
Growing research and development activities in the presence of key market players to increase the demand-supply for injectable potassium phosphate are expected to boost the growth of the Market in the U.S during the forecast period.
Europe Demand Outlook for Injectable Potassium Phosphate Market
In its use to treat potassium and phosphorus deficiencies, potassium phosphates injection is often administered in conjunction with parenteral nutrition treatments.
In Europe large population is aged or ≥12 years and suffering from hypophosphatemia with restricted or no oral intake of potassium phosphate.
Additionally, the rising prevalence renal impairment, urination disorders and end-stage renal disease, has fuelled the demand outlook for injectable potassium phosphate market in Europe.
In recent decades, the European healthcare industry has welcomed advances and new technology with open arms.
Technological developments, the introduction of new materials, the discovery of biosimilars, and research and development efforts, as well as many clinical studies, are some of the key reasons that have enhanced the injectable potassium phosphate market development patterns in Europe.
Who are the Key Manufacturers and Suppliers of Injectable Potassium Phosphate Market
Some of the key players operating in the injectable potassium phosphate market are
- Fresenius Kabi
- PharMEDium Services LLC
- CMP Pharma and American Regent.
Manufacturers in the market focus on carrying out certain strategic activities such as acquisitions and mergers, expansion, product launch, etc. For instance, on May 7, 2020, Fresenius Kabi announced the availability of potassium phosphates injection, USP in three presentations. FDA-approved option for adult and pediatric patients available in 15 mM per 5 mL, 45 mM per 15 mL and 150 mM per 50 mL presentations.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments.
The report also maps the qualitative impact of various market factors on market segments and geographies.
By Doses Forms:
- 5 ml
- 15 ml
- 50 ml
By Route of Administration:
- Peripheral Venous Catheter
- Central Venous Catheter
By End User Type:
- Ambulatory Surgery Centers
- North America
- Latin America
- South Asia
- East Asia
- The Middle East and Africa